Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Multiple Sclerosis 1Meningioma 1Medulloblastoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Surgical Procedures, Operative 2Magnetic Resonance Spectroscopy 2pembrolizumab 1pasireotide 1gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1fluoromisonidazole 1avelumab 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Topotecan 1Temozolomide 1Radiotherapy 1Radiosurgery 1Proton Therapy 1Panobinostat 1Methylphenidate 1Magnetic Resonance Imaging 1Irinotecan 1Ifosfamide 1HDAC-42 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cyclophosphamide 1Congresses as Topic 1Bevacizumab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Meningioma × gadobenic acid × Clear all
NCT02967380 2017-03-27

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

University of Southern California

Phase NA Terminated
14 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Multiple Sclerosis, Oligodendroglioma, Pinealoma, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡